SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021253
Filing Date
2023-05-11
Accepted
2023-05-11 16:14:13
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20230331.htm   iXBRL 10-Q 1953659
2 EX-10.2 cgem-ex10_2.htm EX-10.2 769207
3 EX-31.1 cgem-ex31_1.htm EX-31.1 18009
4 EX-31.2 cgem-ex31_2.htm EX-31.2 17755
5 EX-32.1 cgem-ex32_1.htm EX-32.1 17714
  Complete submission text file 0000950170-23-021253.txt   8536278

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20230331_def.xml EX-101.DEF 176553
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20230331_cal.xml EX-101.CAL 41220
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20230331_lab.xml EX-101.LAB 465305
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20230331.xsd EX-101.SCH 68612
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20230331_pre.xml EX-101.PRE 338839
57 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20230331_htm.xml XML 1436302
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 23911190
SIC: 2836 Biological Products, (No Diagnostic Substances)